Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases

Cytokine Growth Factor Rev. 2017 Dec:38:37-48. doi: 10.1016/j.cytogfr.2017.09.002. Epub 2017 Sep 23.

Abstract

Worldwide increase incidences of allergic diseases have heightened the interest of clinicians and researchers to understand the role of neuroendocrine cells in the recruitment and activation of inflammatory cells. Several pieces of evidence revealed the association of neuropeptides in the pathogenesis of allergic diseases. Importantly, one such peptide that is secreted by neuronal cells and immune cells exerts a wide spectrum of immunological functions as cytokine/chemokine is termed as Vasoactive Intestinal Peptide (VIP). VIP mediates immunological function through interaction with specific receptors namely VPAC-1, VPAC-2, CRTH2 and PAC1 that are expressed on several immune cells such as eosinophils, mast cells, neutrophils, and lymphocytes; therefore, provide the basis for the action of VIP on the immune system. Additionally, VIP mediated action varies according to target organ depending upon the presence of specific VIP associated receptor, involved immune cells and the microenvironment of the organ. Herein, we present an integrative review of the current understanding on the role of VIP and associated receptors in allergic diseases, the presence of VIP receptors on various immune cells with particular emphasis on the role of VIP in the pathogenesis of allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis. Being crucial signal molecule of the neuroendocrine-immune network, the development of stable VIP analogue and/or antagonist may provide the future therapeutic drug alternative for the better treatment of these allergic diseases. Taken together, our current review summarizes the current understandings of VIP biology and further explore the significance of neuroendocrine cells derived VIP in the recruitment of inflammatory cells in allergic diseases that may be helpful to the investigators for planning the experiments and accordingly predicting new therapeutic strategies for combating allergic diseases. Summarized graphical abstract will help the readers to understand the significance of VIP in allergic diseases.

Keywords: Allergy; Asthma; EoE; Eosinophils; Mast cells; VIP.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Hypersensitivity / drug therapy
  • Hypersensitivity / immunology*
  • Neuroendocrine Cells / immunology*
  • Receptors, Vasoactive Intestinal Peptide / immunology
  • Vasoactive Intestinal Peptide / immunology*

Substances

  • Receptors, Vasoactive Intestinal Peptide
  • Vasoactive Intestinal Peptide